Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for bleeding reduction after femoral fracture surgery
IRCT20180422039382N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of tranexamic acid in femoral fracture (2 arms), sponsored by Babol University of Medical Sciences. Primary endpoints: Blood volume lost and Amount of blood received. Started Apr 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
femoral fracture
Beyond the preview
Go deeper on IRCT20180422039382N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180422039382N1.